Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2021

View Archived Issues

Researchers develop a nonhuman primate model of Parkinson's disease

SNS-101, an anti-VISTA antibody, potentiates anti-PD-1/PD-L1 antitumor immunity

GNE-502 shows promising efficacy in breast tumor xenograft model

ALTA-002, a Toll-like receptor agonist antibody conjugate with promising antitumor activity in vivo

Idorsia Pharmaceuticals patents CCR6 antagonists

Novartis synthesizes HIF-2alpha inhibitors

Perha Pharmaceuticals identifies CLK1 and/or CLK4 and/or DYRK1A inhibitors

A novel protein-engineered IL-12 shows efficacy without peripheral toxicity in animal models

Rhizen Pharmaceuticals synthesizes new PARP inhibitors

Preclinical Alzheimer's vaccine, therapy target soluble amyloid

RaQualia Pharma synthesizes new TRPV4 antagonists

Animal model recapitulates CCA susceptibility in progressive biliary injury and fibrosis

Novel CDK9 inhibitors as candidates for the treatment of acute myeloid leukemia

New fully synthetic antibiotic class shows broad activity against multidrug-resistant bacteria

Restoring cellular miR-127-3p inhibits herpesvirus-induced tumorigenesis in vitro and in vivo

Pridopidine has neuroprotective effects mediated by S1R in retinal ganglion cells of glaucoma models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...